Isto Biologics has announced the acquisition of NovaBone Products LLC, enhancing its bone graft substitutes platform. This acquisition allows Isto to broaden its product offerings and strengthen its market presence. NovaBone's innovative synthetic bone grafts support a variety of surgical procedures. This marks Isto's first strategic acquisition after Keensight's investment.
Company Information
Company
Isto Biologics
Location
Hopkinton, Massachusetts, United States
About
Isto Biologics is a leading biologic and cellular therapy company in the orthopedic space. Hopkinton, MA-based Isto Biologics is focused on Helping Patients Heal Faster™ through innovative solutions for bone regeneration and cell-based therapies. The company’s flagship product offerings include the market-leading Magellan® Autologous Platelet Separator, and bone-growth products including InQu® Bone Graft Extender & Substitute, and the Influx™ product family. For more information, visit istobiologics.com
Hopkinton